Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Human monoclonal IgG2 antibody against tissue factor pathway inhibitor

EU orphan designation number: EU/3/18/1979   
Active ingredient: Human monoclonal IgG2 antibody against tissue factor pathway inhibitor
Indication: Treatment of haemophilia A
Sponsor: Bayer AG
D-51368 Leverkusen, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/02/2018 Orphan designation EMA/OD/189/17 (2018)1246 of 22/02/2018
23/08/2018 Corrigendum (2018)1246 of 22/02/2018